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Abstract 
The prevalence of heart failure is 1-2% of the adult population in developing countries. Decreased kidney function 
in these patients is influenced by several factors including low Cardiac Output (CO) (Liu, 2008). Cardiac Index 
(CI) is an important parameter for assessing patients with heart failure since a decrease in CI in heart failure patients 
indicates the inadequacy of tissue perfusion, including the kidney, which triggers Acute Kidney Injury (AKI). 
Thus, it is necessary to study hemodynamic surveillance in patients with heart failure both by using 
echocardiography which is routinely carried out in the Emergency Room (IGD) of the Saiful Anwar Public 
Hospital (RSSA) as well as a Non-invasive Cardiac System (NiCAS) monitoring tool to predict AKI in patients 
with heart failure. 
Methods: Analytical observations were done in 39 patients with heart failure in the Emergency Room of RSSA 
to determine the suitability of NiCAS and echocardiography in measuring CI to predict acute kidney failure in 
these patients. 
Results: The suitability of CI measurements on NiCAS and echocardiography was obtained in 23 samples (59%) 
(p = 0.175). Creatinine suitability and Echocardiography CI R² were 0.0068. Creatinine suitability and NiCAS CI 
were tested at 12th hour, since the patient was hospitalized, under linearity conditions resulting in R2 of 0.0024 and 
R2 0.0287. 
Conclusion: Measurement of NiCAS matches measurement with echocardiography in measuring Cardiac Index. 
However, neither NiCAS nor Echocardiography does not a match in predicting acute kidney failure in patients 
with acute heart failure. 
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Introduction 
The prevalence of heart failure is estimated to reach 1-2% of the adult population in developing countries and is 
mainly experienced by those aged 70 years (Owan, 2006). Heart failure itself can be accompanied by several 
diseases including renal insufficiency or kidney failure. Decreased filtration rate of the renal glomerulus in heart 
failure patients is influenced by factors such as low Cardiac Output (CO), increased intra-abdominal pressure, and 
increased venous pressure (Liu, 2008). 
CO is one of the physiological parameters because it is able to reflect directly and provide a proportional 
picture of metabolism as a whole. CO indexed by body surface area of Cardiac Index (CI) is an important clinical 
parameter and is used to assess patients with heart failure and patients with critical illness. Decreased CO and CI 
in patients with heart failure indicates the inadequacy of tissue perfusion, including perfusion to the kidneys, which 
triggers acute kidney injury (AKI). 
AKI is a condition of sudden kidney function decline within 48 hours. This is marked by an increase in serum 
creatinine > 0.3 mg/dl (> 25 µmol/L), or a 50% increase in serum creatinine, or a decrease in urine production 
(oliguria) < 0.5 ml/kg/hour for > 6 hours (AKIN ) (Murray, 2007). 
A meta-analysis by Smith in 2006 reported that of 80,098 patients treated with heart failure, 63% experienced 
worsening kidney function. The deterioration in kidney function is proportional to the increase in mortality. For 
each increase in serum creatinine level of 0.5 mg/dL, there is an increase in mortality by 15% (Ronco et al., 2010). 
Other studies recommend a scoring system that combines various clinical variables to stratify the risk of 
patients with acute heart failure. However, this recommendation does not provide specific guidelines for therapy 
while hemodynamic monitoring can be an immediate indication for intervention. In addition, modalities such as 
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echocardiography in CO measurements have several limitations, such as difficulty in obtaining continuous 
measurements, periodic measurements can be carried out yet personnel who are able to carry out examinations 
may not always be available, (Huang, 2012) 
Taniguchi et al. conducted a study to measure the cardiac output of heart failure patients without using 
echocardiography, but by using the Non-invasive Cardiac System (NiCAS) as a tool to measure the cardiac output 
with whole-body impedance cardiography. This tool is able to provide an assessment of cardiac output function 
as well as cardiac catheterization, but with non-invasive benefits and no complications (Taniguchi, 2013). 
The deteriorating kidney function in patients with heart failure can be prevented through good hemodynamic 
monitoring (cardiac output) and as there have been no studies comparing hemodynamic monitoring devices, the 
researchers considered it necessary to conduct hemodynamic surveillance studies in patients with heart failure 
using both echocardiography, which is commonly done in the Emergency Room of RSSA and other non-invasive 
monitoring tools (NiCAS) to predict the incidence of acute kidney failure in patients with heart failure. 
 
Material and Method 
This study was an observational analytic study to determine the suitability of NiCAS and echocardiography in 
measuring CI to predict acute kidney failure in patients with heart failure. The inclusion criterion was: patients 
who came to the emergency room at RSSA aged 40 years old and fulfilled clinical criteria for acute heart failure—
the determination of clinical criteria for heart failure was obtained from the anamnesis and physical examination. 
The exclusion criteria included pregnancy, tumor history, with prognosis < 6 months, pneumothorax, anaphylactic 
shock, and acute or critical limb ischemia. 
The independent variables in this study were the clinical characteristics of the patient, the results of laboratory 
measurements, and the CI evaluation of NiCAS and echocardiography. The dependent variable in this study was 
the diagnosis of heart failure. 
The operational definitions in this study were: (1) patients with heart failure, (2) acute renal failure, (3) 
KDIGO AKI criteria, (4) Cardiac Index, (5) echocardiography, and (6) NiCAS. Patients with heart failure are those 
who have a history of heart failure (evidenced by medical records or treatment for patients with heart failure). 
Acute kidney failure is a condition where serum creatinine, urine production, and BUN levels meet the KDIGO 
AKI criteria. The KDIGO AKI criterion is marked by an increase in creatinine of more than 0.3 mg/dL from a 
normal laboratory reference value or urine output of less than 0.5 cc/kg/hour for a period of 6 hours. Cardiac Index 
(CI) is Cardiac Output indexed by body surface area. Cardiac Index in this study can be calculated either using 
echocardiography or NiCAS. 
 
Echocardiography is the use of ultrasonography to see the function of ejection fraction, measuring CO, CI, 
and fluid adequacy in patients with heart failure. Ultrasonography used is GE ultrasonography using a sector probe 
to assess cardiac function. The echocardiography operator was the residents of cardiology. NiCAS is a 
bioimpedance technology that has been approved by the FDA to measure CI components and is non-invasive. 
NiCAS was performed when the patient arrived at the emergency room, in the gurney, in the supine position, had 
no contact with surrounding metal and lower limbs at an angle of 45° and upper abduction at an angle of 30 ° to 
avoid contact with the skin. Measurements with NiCAS would be done again at T 48 hours after hospitalization 
from the emergency room and when the patient was discharged from the hospital. 
 
Results 
The results of the analysis showed the comparison of the use of echocardiography and NiCAS in CI measurements 
to predict acute kidney failure in patients with heart failure according to inclusion criteria. Data collection was 
carried out within 12 months, from December 2017 to December 2018, after the study was approved and declared 
ethical. The study took place at the Emergency Department of RSSA. As many as 39 patients met the inclusion 
criteria. CI measurements were carried out at 12th and 24th hour since the patient was hospitalized using NiCAS 
and at 12th hour since the patient was hospitalized using echocardiography. Measurements of serum creatinine 
were carried out at 12th hour and 24th hour since the patient was hospitalized. Informed consent and statement of 
approval of the research subjects were carried out for all research subjects, namely patients or family members of 
patients in accordance with the existing ethical principles. The general characteristics of the study subjects included 
gender, age, and risk factors (Table 1). Numerical data were tested using the normality test, and because the study 
sample was less than 40, the Sapphiro-Wilk test was used. The Shapiro-Wilk test results showed an abnormal 
distribution (p <0.05), so it was continued with the transformation test. After the transformation test was carried 
out, some of the data still were not normally distributed. The characteristics of the study samples are presented in 
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Table 1. 
Table 1. Characteristics of Research Subjects 
Sex Male 22 (56.4%) 
Female 17 (43.6%) 
Age Average 62.28 years old 
Minimum-Maximum 40-86 years old 
Diabetes Mellitus Yes 11 (28.2%) 
No 28 (71.8%) 
Hypertension Yes 26 (66.7%) 
No 13 (33.3%) 
CAD/ACS Yes 13 (33.3%) 
No 26 (66.7%) 
Heart Failure   
NYHA Class IV 39 (100%) 
Test on the suitability of Cardiac Index on NiCAS and echocardiography at the 12th hour since the patient 
was hospitalized was performed using a paired t-test. Corresponding CI measurements in NiCAS and 
echocardiography were obtained in 23 samples (59%) (p = 0.175) as shown in Table 2. 
Table 2. The Suitability of Cardiac index between NiCAS and Echocardiography at 12th Hour of 
Observation 
CI NiCAS CI echocardiography 
<2.5 or >4 2.5-4 
<2.5 or >4 12 9 
2.5-4 7 11 
The normality test of creatinine serum and Cardiac Index on echocardiography at the 12th hour showed normal 
distribution results in which linearity requirements were met with R² of 0.0068. This means there was a 0.7% 
relationship between 12th-hour measurement of creatinine and CI using echocardiography, while 99.3% was due 
to other factors. The correlation test showed a non-significant relationship between creatinine levels at the 12th 
hour and CI echocardiography at the 12th hour since the patient was hospitalized (p = 0.617, r = 0.083). This is 
presented in Figure 1. 
 
Figure 1. A Correlation Test of Creatinine and Cardiac Index Echocardiography at 12th Hour of 
Observation 
The suitability of creatinine serum and NiCAS Cardiac Index at the 12th hour since the patient was 
hospitalized was tested with a requirement of linearity of R2 of 0.0024, which means there was 0.2% relationship 
between 12th-hour creatinine levels and 12th-hour CI, while 99.8% was due to other factors. The match between 
creatinine and CI levels was found in 18 subjects (46%). The correlation was found not significant between 12th-
hour creatinine levels and 12th-hour CI NiCAS (p = 0.765, r = 0.049). This is presented in Figure 2. 
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Figure 2. A Correlation Test of Creatinine and Cardiac Index NicAS at 12th Hour of Observation 
The suitability of creatinine serum and NiCAS Cardiac Index at the 24th hour since the patient was 
hospitalized was tested with a requirement of linearity of R2 of 0.0287, which means there was 2.8% relationship 
between 24th-hour creatinine levels and 24th-hour CI, while 97.2% was due to other factors. The match between 
creatinine and CI levels was found in 21 subjects (54%) with p = 1. The correlation was found significant between 
24th-hour creatinine levels and 24th-hour CI NiCAS (p = -0.302, r = -0.169). This is presented in Figure 3. 
 
Figure 3. A Correlation Test of Creatinine and Cardiac Index NicAS at 24th Hour of Observation 
 
Discussion 
NiCAS and Echocardiography Cardiac Index   
Echocardiography is now a routine along with a wealth of advance research evidence supporting its use in 
monitoring CO and CI (Lorne, 2014), while Thoracic Bioimpedance Cardiography (ICG) has been widely used in 
recent years as an alternative method of non-invasive, sustainable, operator-dependent, and cost-effective in 
measuring SV and cardiac output. When compared with other cardiac output measurement methods, the most 
preferred method and the algorithm used by the ICG device have an effect on the correlation coefficient on 
echocardiography (Fellahi, 2009). 
NiCAS is a new ICG device that combines central and peripheral hemodynamic monitoring and aims at 
measuring non-invasive advanced hemodynamics, which can be useful in the management of anesthesiology and 
intensive care. NiCAS is also able to capture echocardiogram HR signals to define and measure more accurately 
the systolic, SV, CO and CI time intervals. ICG has also been proven to be a reliable and repeatable method for 
monitoring cardiac output in patients with sepsis. However, the routine use of ICG to monitor cardiac output in 
clinical practice still requires further validation and comparison with other non-invasive hemodynamic tools such 
as echocardiography (Fellahi, 2009). 
This study revealed the suitability of CI measurements between NiCAS and echocardiography in 23 samples 
(59%) and the same result was also found in research by Chen (2014) that there was a correlation between CI 
measurement results using ICG and echocardiography (P <0.05); thus, the data measured by ICG can be used as 
effectively as data from echocardiography in evaluating CI (Chen, 2014). 
A report by Leitman (2016) confirmed the same finding that there was a correlation between CI measurement 
results between NiCAS and echocardiography in patients receiving dobutamine of 0.81 with the CI mean of NiCAS 
and echocardiography of 2.9+0.6 and 2.8+0.6 l/min/m2, respectively. Siedlecka (2014) confirms that the results 
of CI measurements on ICG can be used and have similar results in patients with hypertension, heart failure, and 
rehabilitation after a heart attack. 
Variations in CI measurements by ICG correlated well compared with measurement results using 
echocardiography with r = 0.88 (0.82-0.94), p < 0.001. ICG can be a reliable, non-invasive method for monitoring 
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CI in patients with heart failure (Lorne, 2014). 
The disparity of CI measurement data on NiCAS and echocardiography was also found in 16 samples (41%) 
of the study. Several factors known to influence ICG readings include scar in the chest area, fluid status that affects 
vasodilation or vasoconstriction, the use of continuous positive airway pressure that affects cardiac output, and 
COPD patients due to differences in thoracic cavity volume (Lorne, 2014). 
 
Creatinine Measurement in NiCAS and Echocardiography 
Patients with heart failure often have comorbid kidney disorders and the relationship between the heart and kidneys 
in this condition has become a quite interesting research topic. Kidney disorder in cases of heart failure, called 
cardiorenal syndrome, generally occurs due to left ventricular disorders, which results in decreased CO and CI so 
the kidneys experience hypoperfusion and decreased glomerular filtration rate (Chen, 2017). KDIGO classifies 
acute kidney disorders (AKI) from stages 1 to 3, based on a decrease in the amount of urine or an increase in serum 
creatinine levels or both. This criterion has been validated to predict the main mortality rates of patients in hospitals 
(Kane-Gill, 2015). 
This study found no significant correlation between the reduction in CI measured by NiCAS or 
echocardiography and the increase in serum creatinine measured at 12th and 24th hour since the patient was 
hospitalized in patients with heart failure. The absence of a significant correlation also made it impossible to find 
the CI cut-off value in determining the increase in serum creatinine levels in line with some previous studies. 
A study by Hanberg (2016) showed a non-significant correlation between decreased CI and renal impairment 
as indicated by an increase in creatinine in patients with heart failure—the correlation, however, was weak and 
paradoxical between CI and creatinine increase. The non-linearity test was also not able to find a significant 
positive correlation between CI and creatinine. These findings further emphasize that the reduction in CI is not the 
main trigger for kidney disorders in heart failure patients (Hanberg, 2016). 
Previous studies that also focused on the relationship between CI and kidney function also consistently 
support the findings in this study. In the majority of cases, no significant correlation was found. Only one study 
reported a significant relationship between increased CI and worsening renal function (Mullens, 2009). 
The glomerular filtration rate is a product of the filtration fraction and renal plasma flow, so it will make 
sense if all factors that globally worsened perfusion will also worsen the glomerular filtration rate. The concept of 
decreased CI, which causes kidney disorders in the form of decreased eGFR, increases creatinine and urea seems 
to be too simplified because the kidneys cannot directly feel or respond to the amount of blood pumped into the 
ascending aortic by the heart (cardiac output). Autoregulation in the kidneys, both through the tubuloglomerular 
feedback pathway and myogenic autoregulator, is able to maintain renal perfusion and the filtration rate constantly 
under reduced CI conditions (Hanberg, 2016). 
The study by Nohria (2009) also explained that the reduction in CI was not a major trigger for decreased 
kidney function (defined as an increase in serum creatinine > 0.3 mg/dL) and only had a weak correlation (p < 
0.01). The main factors triggering kidney dysfunction in patients with heart failure is (Nohria, 2009): 
1. Patients as the study subjects tended to be elderly (> 65 years) and had a higher prevalence of comorbidities, 
such as hypertension and diabetes, which caused intrinsic renal disorders and heart failure. 
2. The presence of hypertension and diabetes, especially hypertension, interferes with autoregulation of renal 
blood flow, made this organ more vulnerable to deteriorating function during heart failure therapy. In patients 
with heart failure, the renal autoregulation curve moves to the right, which causes a decrease in Mean Arterial 
Pressure (MAP) as a consequence of decreased blood flow to the kidneys, vasodilation drugs, or diuretics that 
decrease intraglomerular pressure and glomerular filtration rate, which can affect kidney function in normal 
subjects. 
3. Hypertension and diuretic drugs, especially thiazide, combined with diuretic loops are strongly correlated with 
worsening renal function. 
 
Limitation 
This study has several limitations, namely:  
1. Impaired kidney function is reflected by serum creatinine measurements at certain times (12th and 24th hour 
since the patient was hospitalized); most patients with heart failure are assumed to have different kinetic 
variations in the creatinine base values. 
2. Glomerular filtration rate (where creatinine is a measurement element in it) in patients with heart failure is 
affected by a variety of risk factors such as hypertension and diabetes mellitus that can damage the kidneys 
intrinsically before getting involved in this study and this may have dissimulated the correlation between 
“true” heart failure and kidney dysfunction and CI. 
3. The creatinine parameters used in this study were not dominantly influenced by kidney damage such as 
damage to tubular function, but rather to muscle damage; thus, future studies need to examine the relationship 
between the decrease in CI with kidney function parameters such as tubular damage (like cystatin C). 
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Conclusions 
 The measurement of NiCAS as a non-invasive impedance method was suitable in measuring cardiac index as 
it showed the same results as shown by echocardiography. 
 Echocardiography was suitable to be used in cardiac index measurements to predict acute kidney failure in 
patients with acute kidney failure in 20 samples (p = 0.648). Statistical tests showed that there was no 
significant relationship between CI echocardiography and increased serum creatinine levels. 
 NiCAS was suitable to be used in cardiac index measurements at the 12th hour and the 24th hour since the 
patient was hospitalized. It was showing the suitability of 18 samples at the 12th hour since the patient was 
hospitalized. However, at the 24th hour since the patient was hospitalized, the test showed no significant 
relationship. 
 There was no matching cardiac index measurement using echocardiography or using NiCAS in predicting 
acute kidney failure in patients with acute heart failure. 
 
Suggestions 
 The Emergency Room of Syaiful Anwar Public Hospital (RSSA) can consider the use of NiCAS as a non-
invasive monitoring tool for cardiac function because it has the same reliability as echocardiography. 
 Further studies on the relationship between a decrease in cardiac index and the main parameters of kidney 
function such as tubular damage (such as cystatin C) must be done. 
 
References 
Abuelo, J.G., 2007. Normotensive ischemic acute renal failure. New England Journal of Medicine, 357(8), pp.797-
805. 
Berton, C. and Cholley, B., 2002. Equipment review: new techniques for cardiac output measurement–oesophageal 
Doppler, Fick principle using carbon dioxide, and pulse contour analysis. Critical Care, 6(3), p.216. 
Bougault, V., Lonsdorfer-Wolf, E., Charloux, A., Richard, R., Geny, B. and Oswald-Mammosser, M., 2005. Does 
thoracic bioimpedance accurately determine cardiac output in COPD patients during maximal or intermittent 
exercise?. Chest, 127(4), pp.1122-1131. 
Bui, A.L., Horwich, T.B. and Fonarow, G.C., 2011. Epidemiology and risk profile of heart failure. Nature Reviews 
Cardiology, 8(1), p.30. 
Chittineni, H., Miyawaki, N., Gulipelli, S. and Fishbane, S., 2007. The risk for acute renal failure in patients 
hospitalized for decompensated congestive heart failure. American journal of nephrology, 27(1), pp.55-62. 
Forman, D.E., Butler, J., Wang, Y., Abraham, W.T., O'Connor, C.M., Gottlieb, S.S., Loh, E., Massie, B.M., Rich, 
M.W., Stevenson, L.W. and Young, J.B., 2004. Incidence, predictors at admission, and impact of worsening 
renal function among patients hospitalized with heart failure. Journal of the American College of 
Cardiology, 43(1), pp.61-67. 
Hett, D.A. and Jonas, M.M., 2003. Non-invasive cardiac output monitoring. Current Anaesthesia & Critical 
Care, 14(4), pp.187-191. 
Isselbacher, E.M., Pasternak, R.C., Criqui, M.H., Benjamin, E.J., Fowkes, F.G.R., McCullough, P.A., Wolf, P.A. 
and Zheng, Z.J., 2012. Atherosclerotic vascular disease conference: writing group I: 
epidemiology. Circulation, 109(21), pp.2605-2612. 
Kaufmann, P.A., Jiang, Z., Attenhofer, C., Linka, A. and Mandinov, L., 2000. In vitro validation of volumetric 
blood flow measurement using Doppler flow wire. Ultrasound in medicine & biology, 26(8), pp.1301-1310. 
Kemp, C.D. and Conte, J.V., 2012. The pathophysiology of heart failure. Cardiovascular Pathology, 21(5), 
pp.365-371. 
Liu, P.P., 2008. Cardiorenal syndrome in heart failure: a cardiologist's perspective. Canadian Journal of 
Cardiology, 24, pp.25B-29B. 
Lavdaniti, M., 2008. Invasive and non-invasive methods for cardiac output measurement. International Journal of 
Caring Sciences, 1(3), p.112. 
Matthew, B., Singh, P.M., Dhillon, M.S. and Hunt, K.R., Tosense Inc, 2016. Body-worn sensor for characterizing 
patients with heart failure. U.S. Patent 9,259,183. 
Murray, P.T., Roy, A.K., Mc Gorrian, C., Treacy, C., Kavanaugh, E., Brennan, A., and Mahon, N.G., 2013. A 
comparison of traditional and novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the 
prediction of outcomes in acute decompensated heart failure. Cardiorenal medicine, 3(1), pp.26-37. 
Nowak, R.M., Nanayakkara, P., DiSomma, S., Levy, P., Schrijver, E., Huyghe, R., Autunno, A., Sherwin, R.L., 
Divine, G. and Moyer, M., 2014. Noninvasive hemodynamic monitoring in emergency patients with 
suspected heart failure, sepsis and stroke: the PREMIUM registry. Western Journal of Emergency 
Medicine, 15(7), p.786. 
Owan, T.E., Hodge, D.O., Herges, R.M., Jacobsen, S.J., Roger, V.L. and Redfield, M.M., 2006. Secular trends in 
renal dysfunction and outcomes in hospitalized heart failure patients. Journal of cardiac failure, 12(4), 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal DOI: 10.7176/JHMN 
Vol.66, 2019 
 
7 
pp.257-262. 
Packer, M., Abraham, W.T., Mehra, M.R., Yancy, C.W., Lawless, C.E., Mitchell, J.E., Smart, F.W., Bijou, R., 
O’Connor, C.M., Massie, B.M. and Pina, I.L., 2006. Utility of impedance cardiography for the identification 
of short-term risk of clinical decompensation in stable patients with chronic heart failure. Journal of the 
American College of Cardiology, 47(11), pp.2245-2252. 
Philipp K., Hafer, C., Lukasz, A., Lichtinghagen, R., Brand, K., Fliser, D., Faulhaber-Walter, R. and Kielstein, 
J.T., 2010. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts 
survival in critically ill patients with acute kidney injury. Critical care, 14(1), p.R9. 
Prabhu, M., 2007. Cardiac output measurement. Anaesthesia & Intensive Care Medicine, 8(2), pp.63-66. 
Prentice, D. and Sona, C., 2006. Esophageal Doppler monitoring for hemodynamic assessment. Critical care 
nursing clinics of North America, 18(2), pp.189-93. 
Roger, V.L., 2013. Epidemiology of heart failure. Circulation research, 113(6), pp.646-659. 
Ronco, C., Goh, C.Y., Haase‐Fielitz, A., Cruz, D.N.. and Haase, M., 2010. Early biomarkers of renal 
injury. Congestive heart failure, 16, pp.S25-S31. 
Sachin, S.S., Sabool, S.S., Raman, A. and Chakravartis, R.M., 2010. New Biomarkers in Acute Kidney 
Injury. Nephrology and Clinical Chemistry: The Essential Link, p.49. 
Sean, B.M., George, C. and Bellomo, R., 2008. A comparison of the RIFLE and AKIN criteria for acute kidney 
injury in critically ill patients. Nephrology Dialysis Transplantation, 23(5), pp.1569-1574. 
Smith, G.L., Lichtman, J.H., Bracken, M.B., Shlipak, M.G., Phillips, C.O., DiCapua, P. and Krumholz, H.M., 
2006. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. Journal of the 
American College of Cardiology, 47(10), pp.1987-1996. 
Springfield, G.S., and Wang, D.J., 2006. Impedance cardiography: more questions than answers. Current heart 
failure reports, 3(3), pp.107-113. 
Taniguchi, Y., Emoto, N., Miyagawa, K., Nakayama, K., Kinutani, H., Tanaka, H., Shinke, T. and Hirata, K.I., 
2013. Noninvasive and simple assessment of cardiac output and pulmonary vascular resistance with whole-
body impedance cardiography is useful for monitoring patients with pulmonary hypertension. Circulation 
Journal, 77(9), pp.2383-2389. 
Tanino, Y., Shite, J., Paredes, O.L., Shinke, T., Ogasawara, D., Sawada, T., Kawamori, H., Miyoshi, N., Kato, H., 
Yoshino, N. and Hirata, K.I., 2009. Whole body bioimpedance monitoring for outpatient chronic heart failure 
follow up. Circulation Journal, 73(6), pp.1074-1079. 
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H., Fonarow, G.C., Geraci, S.A., 
Horwich, T., Januzzi, J.L. and Johnson, M.R., 2013. 2013 ACCF/AHA guideline for the management of heart 
failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force 
on Practice Guidelines. Journal of the American College of Cardiology, 62(16), pp.e147-e239 
 
 
